SteinCares
  • Home
  • Company
    • Who We are
    • Our Milestones
    • Our Presence
  • Business Segments
    • Innovative
    • Biosimilars
    • Complex Generics
    • Therapeutic Areas
  • Partnerships
    • Pillars of Successful Partnerships
    • Our Partnership Solutions
  • Press Releases
  • Contact us
  • ESP
Select Page
Lupin and SteinCares Enter into License and Supply Agreement for Ranibizumab in Latin America

Lupin and SteinCares Enter into License and Supply Agreement for Ranibizumab in Latin America

by victoria.carrillo | May 26, 2025 | Press Releases

This deal strengthens SteinCares’ leadership in the biosimilar segment across Latin America with this treatment for diverse ophthalmological diseases. The partnership will result in significant cost savings for institutions in the region by providing access to a...

Recent Posts

  • SteinCares Opens New Facility in Costa Rica to Strengthen Access to Specialty Healthcare Across Latin America
  • SteinCares Enters the Mexican Market Through a Strategic Joint Venture with Laboratorios Carnot
  • Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America
  • Lupin and SteinCares Enter into License and Supply Agreement for Ranibizumab in Latin America
  • SteinCares and Pharmacosmos Launch Monofer® in Six New Latin American Markets to Address Iron Deficiency

Recent Comments

No comments to show.